Rachael A. Safyan

An association study of inflammatory cytokine gene polymorphisms in Fabry disease.

Rachael A. Safyan, Catharina Whybra, Michael Beck et al. · PubMed · 2006 · 23 citations

Life Sciences, Genetics, Immunology +16

Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma

Chih‐Ching Yeh, Abhishek Goyal, Jing Shen et al. · Annals of Surgical Oncology · 2017 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE).

J. Randolph Hecht, Ardaman Shergill, Mark Gregory Goldstein et al. · Journal of Clinical Oncology · 2022 · 17 citations

Life Sciences, Immunology, Pharmacology +17

Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205).

Kian‐Huat Lim, Kristen Spencer, Rachael A. Safyan et al. · Journal of Clinical Oncology · 2024 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +15

Phase 2 study of azacitidine (AZA) plus pembrolizumab (pembro) as second-line treatment in patients with advanced pancreatic ductal adenocarcinoma.

Rachael A. Safyan, Gulam A. Manji, Shing Mirn Lee et al. · Journal of Clinical Oncology · 2022 · 11 citations

Medicine, Oncology, Pharmacology +17